Layla Taylor reveals her eating disorder struggle on "Mormon Wives." She weighs just 99 pounds at 5'10" and says she's unable to stop destructive patterns.
If you’ve read anything about popular weight-loss injection medications like Ozempic or Wegovy, you’ve likely come across the term GLP-1. Short for glucagon-like peptide-1, GLP-1 is a hormone ...
Serena Williams once again modeled a swimsuit following backlash over her use of weight loss medication, Ro. The tennis champion was pictured via Instagram wearing an olive green one-piece swimsuit ...
Medications known as GLP-1 receptor agonists have become some of the most popular treatments for weight loss in recent years. These drugs, originally developed to help people with diabetes control ...
Every bite matters when you start taking a GLP-1. Prioritizing nutrient-dense foods that support your gut and digestive health and maintaining proper hydration can make a real difference in your ...
Zepbound KwikPen, Eli Lilly's multi-dose weight-management injection, is available at participating Kroger Family of Pharmacies locations.
As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings. A new Cleveland Clinic analysis of nearly 8,000 ...
The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use ...
Kroger’s retail rollout shifts Zepbound KwikPen distribution from direct-to-consumer to community pharmacy channels, potentially reducing friction in initiation and refills for GLP-1 obesity therapy.
The Kroger Co. announced on March 13 that its pharmacies have begun stocking Zepbound KwikPen, Eli Lilly’s new multi-dose weight management pen. This news is especially important for self-pay patients ...
Thinking about Omada Health for your well-being? It’s a digital program that aims to help folks manage long-term health issues through lifestyle changes. We’re going to take a look at what Omada ...
GLP-1 receptor agonists like semaglutide are being used off-label by healthy people hoping to slow ageing, despite limited evidence and unknown long-term risks.